Back to School: How biopharma can reboot drug development. Access exclusive analysis here

EraGen: Applying evolution to revolution

The company originally was founded as Sulfonics Inc., based on technology for non-charged sulfone modifications to the DNA backbone for antisense applications. With the growing emphasis on genomics, the company shifted focus to technologies derived from the study of evolutionary relationships between gene sequences, and in 1999 reincorporated as EraGen.

EraGen now is centered on a bioinformatics platform called Master Catalog that it uses to define evolutionarily related gene families for

Read the full 709 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers